The authors found that Man-Lf NPs led to increased calreticulin (CRT) expression on the tumor cell membrane, accumulated significantly in tumors, and demonstrated superior anti-tumor efficacy in CT26 tumor-bearing mice compared to other drugs and Lf NPs. The gene discussed is CALR; the disease is neoplasm.